group X sPLA₂ Antibodies

Santa Cruz Biotechnology delivers a wide array of group X sPLA₂ monoclonal antibodies for advanced research in lipid metabolism and inflammation. Group X sPLA₂ monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Group X sPLA₂ plays a critical role in the hydrolysis of phospholipids, leading to the release of arachidonic acid, a precursor for bioactive lipid mediators involved in inflammatory responses. Understanding the function of group X sPLA₂ is essential for elucidating its contributions to various physiological and pathological processes, including cardiovascular diseases and cancer. The study of group X sPLA₂ is vital for developing therapeutic strategies targeting inflammation and related disorders. Researchers worldwide rely on group X sPLA₂ monoclonal antibodies to advance their understanding of lipid signaling pathways. Group X sPLA₂ monoclonal antibodies enable precise detection and analysis of target molecules in various experimental settings. Santa Cruz Biotechnology monoclonal antibodies support researchers in their mission to unlock new insights into lipid metabolism and inflammation, contributing to the advancement of scientific knowledge and potential therapeutic developments.